Request for Covid-19 Impact Assessment of this Report
The United States Drugs Based on Gene Therapy market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Drugs Based on Gene Therapy market, reaching US$ million by the year 2028. As for the Europe Drugs Based on Gene Therapy landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Drugs Based on Gene Therapy players cover Biogen, Novartis, Gilead Sciences, and Sarepta Therapeutics, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Drugs Based on Gene Therapy market by product type, application, key players and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022 in Section 2.3; and forecast to 2028 in section 10.7.
Based on Viral
Based on Non-viral
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 10.8.
Neurological Diseases
Cancer
Other
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the major players in the market. The key players covered in this report: Breakdown data in in Chapter 3.
Biogen
Novartis
Gilead Sciences
Sarepta Therapeutics
Alnylam Pharmaceuticals
Amgen
Spark Therapeutics
Akcea Therapeutics
Bluebird bio
Sunway Biotech
SIBIONO
AnGes
Orchard Therapeutics
Human Stem Cells Institute
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Drugs Based on Gene Therapy Market Size 2017-2028
2.1.2 Drugs Based on Gene Therapy Market Size CAGR by Region 2017 VS 2022 VS 2028
2.2 Drugs Based on Gene Therapy Segment by Type
2.2.1 Based on Viral
2.2.2 Based on Non-viral
2.3 Drugs Based on Gene Therapy Market Size by Type
2.3.1 Drugs Based on Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028)
2.3.2 Global Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
2.4 Drugs Based on Gene Therapy Segment by Application
2.4.1 Neurological Diseases
2.4.2 Cancer
2.4.3 Other
2.5 Drugs Based on Gene Therapy Market Size by Application
2.5.1 Drugs Based on Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028)
2.5.2 Global Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
3 Drugs Based on Gene Therapy Market Size by Player
3.1 Drugs Based on Gene Therapy Market Size Market Share by Players
3.1.1 Global Drugs Based on Gene Therapy Revenue by Players (2020-2022)
3.1.2 Global Drugs Based on Gene Therapy Revenue Market Share by Players (2020-2022)
3.2 Global Drugs Based on Gene Therapy Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 Drugs Based on Gene Therapy by Regions
4.1 Drugs Based on Gene Therapy Market Size by Regions (2017-2022)
4.2 Americas Drugs Based on Gene Therapy Market Size Growth (2017-2022)
4.3 APAC Drugs Based on Gene Therapy Market Size Growth (2017-2022)
4.4 Europe Drugs Based on Gene Therapy Market Size Growth (2017-2022)
4.5 Middle East & Africa Drugs Based on Gene Therapy Market Size Growth (2017-2022)
5 Americas
5.1 Americas Drugs Based on Gene Therapy Market Size by Country (2017-2022)
5.2 Americas Drugs Based on Gene Therapy Market Size by Type (2017-2022)
5.3 Americas Drugs Based on Gene Therapy Market Size by Application (2017-2022)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Drugs Based on Gene Therapy Market Size by Region (2017-2022)
6.2 APAC Drugs Based on Gene Therapy Market Size by Type (2017-2022)
6.3 APAC Drugs Based on Gene Therapy Market Size by Application (2017-2022)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 Europe
7.1 Europe Drugs Based on Gene Therapy by Country (2017-2022)
7.2 Europe Drugs Based on Gene Therapy Market Size by Type (2017-2022)
7.3 Europe Drugs Based on Gene Therapy Market Size by Application (2017-2022)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Drugs Based on Gene Therapy by Region (2017-2022)
8.2 Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2017-2022)
8.3 Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2017-2022)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Global Drugs Based on Gene Therapy Market Forecast
10.1 Global Drugs Based on Gene Therapy Forecast by Regions (2023-2028)
10.1.1 Global Drugs Based on Gene Therapy Forecast by Regions (2023-2028)
10.1.2 Americas Drugs Based on Gene Therapy Forecast
10.1.3 APAC Drugs Based on Gene Therapy Forecast
10.1.4 Europe Drugs Based on Gene Therapy Forecast
10.1.5 Middle East & Africa Drugs Based on Gene Therapy Forecast
10.2 Americas Drugs Based on Gene Therapy Forecast by Country (2023-2028)
10.2.1 United States Drugs Based on Gene Therapy Market Forecast
10.2.2 Canada Drugs Based on Gene Therapy Market Forecast
10.2.3 Mexico Drugs Based on Gene Therapy Market Forecast
10.2.4 Brazil Drugs Based on Gene Therapy Market Forecast
10.3 APAC Drugs Based on Gene Therapy Forecast by Region (2023-2028)
10.3.1 China Drugs Based on Gene Therapy Market Forecast
10.3.2 Japan Drugs Based on Gene Therapy Market Forecast
10.3.3 Korea Drugs Based on Gene Therapy Market Forecast
10.3.4 Southeast Asia Drugs Based on Gene Therapy Market Forecast
10.3.5 India Drugs Based on Gene Therapy Market Forecast
10.3.6 Australia Drugs Based on Gene Therapy Market Forecast
10.4 Europe Drugs Based on Gene Therapy Forecast by Country (2023-2028)
10.4.1 Germany Drugs Based on Gene Therapy Market Forecast
10.4.2 France Drugs Based on Gene Therapy Market Forecast
10.4.3 UK Drugs Based on Gene Therapy Market Forecast
10.4.4 Italy Drugs Based on Gene Therapy Market Forecast
10.4.5 Russia Drugs Based on Gene Therapy Market Forecast
10.5 Middle East & Africa Drugs Based on Gene Therapy Forecast by Region (2023-2028)
10.5.1 Egypt Drugs Based on Gene Therapy Market Forecast
10.5.2 South Africa Drugs Based on Gene Therapy Market Forecast
10.5.3 Israel Drugs Based on Gene Therapy Market Forecast
10.5.4 Turkey Drugs Based on Gene Therapy Market Forecast
10.5.5 GCC Countries Drugs Based on Gene Therapy Market Forecast
10.6 Global Drugs Based on Gene Therapy Forecast by Type (2023-2028)
10.7 Global Drugs Based on Gene Therapy Forecast by Application (2023-2028)
11 Key Players Analysis
11.1 Biogen
11.1.1 Biogen Company Information
11.1.2 Biogen Drugs Based on Gene Therapy Product Offered
11.1.3 Biogen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.1.4 Biogen Main Business Overview
11.1.5 Biogen Latest Developments
11.2 Novartis
11.2.1 Novartis Company Information
11.2.2 Novartis Drugs Based on Gene Therapy Product Offered
11.2.3 Novartis Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.2.4 Novartis Main Business Overview
11.2.5 Novartis Latest Developments
11.3 Gilead Sciences
11.3.1 Gilead Sciences Company Information
11.3.2 Gilead Sciences Drugs Based on Gene Therapy Product Offered
11.3.3 Gilead Sciences Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.3.4 Gilead Sciences Main Business Overview
11.3.5 Gilead Sciences Latest Developments
11.4 Sarepta Therapeutics
11.4.1 Sarepta Therapeutics Company Information
11.4.2 Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
11.4.3 Sarepta Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.4.4 Sarepta Therapeutics Main Business Overview
11.4.5 Sarepta Therapeutics Latest Developments
11.5 Alnylam Pharmaceuticals
11.5.1 Alnylam Pharmaceuticals Company Information
11.5.2 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
11.5.3 Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.5.4 Alnylam Pharmaceuticals Main Business Overview
11.5.5 Alnylam Pharmaceuticals Latest Developments
11.6 Amgen
11.6.1 Amgen Company Information
11.6.2 Amgen Drugs Based on Gene Therapy Product Offered
11.6.3 Amgen Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.6.4 Amgen Main Business Overview
11.6.5 Amgen Latest Developments
11.7 Spark Therapeutics
11.7.1 Spark Therapeutics Company Information
11.7.2 Spark Therapeutics Drugs Based on Gene Therapy Product Offered
11.7.3 Spark Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.7.4 Spark Therapeutics Main Business Overview
11.7.5 Spark Therapeutics Latest Developments
11.8 Akcea Therapeutics
11.8.1 Akcea Therapeutics Company Information
11.8.2 Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
11.8.3 Akcea Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.8.4 Akcea Therapeutics Main Business Overview
11.8.5 Akcea Therapeutics Latest Developments
11.9 Bluebird bio
11.9.1 Bluebird bio Company Information
11.9.2 Bluebird bio Drugs Based on Gene Therapy Product Offered
11.9.3 Bluebird bio Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.9.4 Bluebird bio Main Business Overview
11.9.5 Bluebird bio Latest Developments
11.10 Sunway Biotech
11.10.1 Sunway Biotech Company Information
11.10.2 Sunway Biotech Drugs Based on Gene Therapy Product Offered
11.10.3 Sunway Biotech Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.10.4 Sunway Biotech Main Business Overview
11.10.5 Sunway Biotech Latest Developments
11.11 SIBIONO
11.11.1 SIBIONO Company Information
11.11.2 SIBIONO Drugs Based on Gene Therapy Product Offered
11.11.3 SIBIONO Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.11.4 SIBIONO Main Business Overview
11.11.5 SIBIONO Latest Developments
11.12 AnGes
11.12.1 AnGes Company Information
11.12.2 AnGes Drugs Based on Gene Therapy Product Offered
11.12.3 AnGes Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.12.4 AnGes Main Business Overview
11.12.5 AnGes Latest Developments
11.13 Orchard Therapeutics
11.13.1 Orchard Therapeutics Company Information
11.13.2 Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
11.13.3 Orchard Therapeutics Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.13.4 Orchard Therapeutics Main Business Overview
11.13.5 Orchard Therapeutics Latest Developments
11.14 Human Stem Cells Institute
11.14.1 Human Stem Cells Institute Company Information
11.14.2 Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
11.14.3 Human Stem Cells Institute Drugs Based on Gene Therapy Revenue, Gross Margin and Market Share (2020-2022)
11.14.4 Human Stem Cells Institute Main Business Overview
11.14.5 Human Stem Cells Institute Latest Developments
12 Research Findings and Conclusion
Table 1. Drugs Based on Gene Therapy Market Size CAGR by Region (2017 VS 2022 VS 2028) & ($ Millions)
Table 2. Major Players of Based on Viral
Table 3. Major Players of Based on Non-viral
Table 4. Drugs Based on Gene Therapy Market Size CAGR by Type (2017 VS 2022 VS 2028) & ($ Millions)
Table 5. Global Drugs Based on Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 6. Global Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
Table 7. Drugs Based on Gene Therapy Market Size CAGR by Application (2017 VS 2022 VS 2028) & ($ Millions)
Table 8. Global Drugs Based on Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 9. Global Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
Table 10. Global Drugs Based on Gene Therapy Revenue by Players (2020-2022) & ($ Millions)
Table 11. Global Drugs Based on Gene Therapy Revenue Market Share by Player (2020-2022)
Table 12. Drugs Based on Gene Therapy Key Players Head office and Products Offered
Table 13. Drugs Based on Gene Therapy Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Drugs Based on Gene Therapy Market Size by Regions 2017-2022 & ($ Millions)
Table 17. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2017-2022)
Table 18. Americas Drugs Based on Gene Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 19. Americas Drugs Based on Gene Therapy Market Size Market Share by Country (2017-2022)
Table 20. Americas Drugs Based on Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 21. Americas Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
Table 22. Americas Drugs Based on Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 23. Americas Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
Table 24. APAC Drugs Based on Gene Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 25. APAC Drugs Based on Gene Therapy Market Size Market Share by Region (2017-2022)
Table 26. APAC Drugs Based on Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 27. APAC Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
Table 28. APAC Drugs Based on Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 29. APAC Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
Table 30. Europe Drugs Based on Gene Therapy Market Size by Country (2017-2022) & ($ Millions)
Table 31. Europe Drugs Based on Gene Therapy Market Size Market Share by Country (2017-2022)
Table 32. Europe Drugs Based on Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 33. Europe Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
Table 34. Europe Drugs Based on Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 35. Europe Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
Table 36. Middle East & Africa Drugs Based on Gene Therapy Market Size by Region (2017-2022) & ($ Millions)
Table 37. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region (2017-2022)
Table 38. Middle East & Africa Drugs Based on Gene Therapy Market Size by Type (2017-2022) & ($ Millions)
Table 39. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type (2017-2022)
Table 40. Middle East & Africa Drugs Based on Gene Therapy Market Size by Application (2017-2022) & ($ Millions)
Table 41. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application (2017-2022)
Table 42. Key Market Drivers & Growth Opportunities of Drugs Based on Gene Therapy
Table 43. Key Market Challenges & Risks of Drugs Based on Gene Therapy
Table 44. Key Industry Trends of Drugs Based on Gene Therapy
Table 45. Global Drugs Based on Gene Therapy Market Size Forecast by Regions (2023-2028) & ($ Millions)
Table 46. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Regions (2023-2028)
Table 47. Global Drugs Based on Gene Therapy Market Size Forecast by Type (2023-2028) & ($ Millions)
Table 48. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Type (2023-2028)
Table 49. Global Drugs Based on Gene Therapy Market Size Forecast by Application (2023-2028) & ($ Millions)
Table 50. Global Drugs Based on Gene Therapy Market Size Market Share Forecast by Application (2023-2028)
Table 51. Biogen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 52. Biogen Drugs Based on Gene Therapy Product Offered
Table 53. Biogen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 54. Biogen Main Business
Table 55. Biogen Latest Developments
Table 56. Novartis Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 57. Novartis Drugs Based on Gene Therapy Product Offered
Table 58. Novartis Main Business
Table 59. Novartis Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 60. Novartis Latest Developments
Table 61. Gilead Sciences Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 62. Gilead Sciences Drugs Based on Gene Therapy Product Offered
Table 63. Gilead Sciences Main Business
Table 64. Gilead Sciences Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 65. Gilead Sciences Latest Developments
Table 66. Sarepta Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 67. Sarepta Therapeutics Drugs Based on Gene Therapy Product Offered
Table 68. Sarepta Therapeutics Main Business
Table 69. Sarepta Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 70. Sarepta Therapeutics Latest Developments
Table 71. Alnylam Pharmaceuticals Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 72. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Product Offered
Table 73. Alnylam Pharmaceuticals Main Business
Table 74. Alnylam Pharmaceuticals Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 75. Alnylam Pharmaceuticals Latest Developments
Table 76. Amgen Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 77. Amgen Drugs Based on Gene Therapy Product Offered
Table 78. Amgen Main Business
Table 79. Amgen Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 80. Amgen Latest Developments
Table 81. Spark Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 82. Spark Therapeutics Drugs Based on Gene Therapy Product Offered
Table 83. Spark Therapeutics Main Business
Table 84. Spark Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 85. Spark Therapeutics Latest Developments
Table 86. Akcea Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 87. Akcea Therapeutics Drugs Based on Gene Therapy Product Offered
Table 88. Akcea Therapeutics Main Business
Table 89. Akcea Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 90. Akcea Therapeutics Latest Developments
Table 91. Bluebird bio Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 92. Bluebird bio Drugs Based on Gene Therapy Product Offered
Table 93. Bluebird bio Main Business
Table 94. Bluebird bio Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 95. Bluebird bio Latest Developments
Table 96. Sunway Biotech Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 97. Sunway Biotech Drugs Based on Gene Therapy Product Offered
Table 98. Sunway Biotech Main Business
Table 99. Sunway Biotech Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 100. Sunway Biotech Latest Developments
Table 101. SIBIONO Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 102. SIBIONO Drugs Based on Gene Therapy Product Offered
Table 103. SIBIONO Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 104. SIBIONO Main Business
Table 105. SIBIONO Latest Developments
Table 106. AnGes Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 107. AnGes Drugs Based on Gene Therapy Product Offered
Table 108. AnGes Main Business
Table 109. AnGes Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 110. AnGes Latest Developments
Table 111. Orchard Therapeutics Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 112. Orchard Therapeutics Drugs Based on Gene Therapy Product Offered
Table 113. Orchard Therapeutics Main Business
Table 114. Orchard Therapeutics Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 115. Orchard Therapeutics Latest Developments
Table 116. Human Stem Cells Institute Details, Company Type, Drugs Based on Gene Therapy Area Served and Its Competitors
Table 117. Human Stem Cells Institute Drugs Based on Gene Therapy Product Offered
Table 118. Human Stem Cells Institute Main Business
Table 119. Human Stem Cells Institute Drugs Based on Gene Therapy Revenue ($ million), Gross Margin and Market Share (2020-2022)
Table 120. Human Stem Cells Institute Latest Developments
List of Figures
Figure 1. Drugs Based on Gene Therapy Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Drugs Based on Gene Therapy Market Size Growth Rate 2017-2028 ($ Millions)
Figure 6. Global Drugs Based on Gene Therapy Market Size Market Share by Type in 2021
Figure 7. Drugs Based on Gene Therapy in Neurological Diseases
Figure 8. Global Drugs Based on Gene Therapy Market: Neurological Diseases (2017-2022) & ($ Millions)
Figure 9. Drugs Based on Gene Therapy in Cancer
Figure 10. Global Drugs Based on Gene Therapy Market: Cancer (2017-2022) & ($ Millions)
Figure 11. Drugs Based on Gene Therapy in Other
Figure 12. Global Drugs Based on Gene Therapy Market: Other (2017-2022) & ($ Millions)
Figure 13. Global Drugs Based on Gene Therapy Market Size Market Share by Application in 2021
Figure 14. Global Drugs Based on Gene Therapy Revenue Market Share by Player in 2021
Figure 15. Global Drugs Based on Gene Therapy Market Size Market Share by Regions (2017-2022)
Figure 16. Americas Drugs Based on Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 17. APAC Drugs Based on Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 18. Europe Drugs Based on Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 19. Middle East & Africa Drugs Based on Gene Therapy Market Size 2017-2022 ($ Millions)
Figure 20. Americas Drugs Based on Gene Therapy Value Market Share by Country in 2021
Figure 21. Americas Drugs Based on Gene Therapy Consumption Market Share by Type in 2021
Figure 22. Americas Drugs Based on Gene Therapy Market Size Market Share by Application in 2021
Figure 23. United States Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 24. Canada Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 25. Mexico Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 26. Brazil Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 27. APAC Drugs Based on Gene Therapy Market Size Market Share by Region in 2021
Figure 28. APAC Drugs Based on Gene Therapy Market Size Market Share by Application in 2021
Figure 29. China Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 30. Japan Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 31. Korea Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 32. Southeast Asia Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 33. India Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 34. Australia Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 35. Europe Drugs Based on Gene Therapy Market Size Market Share by Country in 2021
Figure 36. Europe Drugs Based on Gene Therapy Market Size Market Share by Type in 2021
Figure 37. Europe Drugs Based on Gene Therapy Market Size Market Share by Application in 2021
Figure 38. Germany Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 39. France Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 40. UK Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 41. Italy Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 42. Russia Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 43. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Region in 2021
Figure 44. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Type in 2021
Figure 45. Middle East & Africa Drugs Based on Gene Therapy Market Size Market Share by Application in 2021
Figure 46. Egypt Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 47. South Africa Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 48. Israel Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 49. Turkey Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 50. GCC Country Drugs Based on Gene Therapy Market Size Growth 2017-2022 ($ Millions)
Figure 51. Americas Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 52. APAC Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 53. Europe Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 54. Middle East & Africa Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 55. United States Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 56. Canada Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 57. Mexico Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 58. Brazil Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 59. China Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 60. Japan Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 61. Korea Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 62. Southeast Asia Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 63. India Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 64. Australia Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 65. Germany Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 66. France Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 67. UK Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 68. Italy Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 69. Russia Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 70. Spain Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 71. Egypt Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 72. South Africa Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 73. Israel Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 74. Turkey Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
Figure 75. GCC Countries Drugs Based on Gene Therapy Market Size 2023-2028 ($ Millions)
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...